CYP Still has plenty of legs from it's current SP/Mcap I agree. Eager to see where they are at in another year or two. Health industry as a whole will be in for a good year IMO. Particularly Stem cells and Tech health. MEB, CYP, IMU, PTX, etc.
AN1 CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks
